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Once cancer is initiated, with normal cells mutated into malignant ones, a solid
tumour grows, develops and spreads within its microenvironment invading the
local tissue; the disease progresses and the cancer cells migrate around the body
leading to metastasis, the formation of distant secondary tumours. Interactions
between the tumour and itsmicroenvironment drive this cascade of eventswhich
have devastating, if not fatal, consequences for the human host/patient. Among
these interactions, biomechanical interactions are a vital component. In this
review paper, key biomechanical relationships are discussed through a presenta-
tion of modelling efforts by the mathematical and computational oncology com-
munity. The main focus is directed, naturally, towards lattice-free agent-based,
force-based models of solid tumour growth and development. In such models,
interactions between pairs of cancer cells (as well as between cells and other
structures of the tumourmicroenvironment) are governed by forces. These forces
are ones of repulsion and adhesion, and are typically modelled via either an
extended Hertz model of contact mechanics or using Johnson–Kendal–Roberts
theory, both of which are discussed here. The role of the extracellular matrix
in determining disease progression is outlined along with important cell-vessel
interactionswhich combined together account for a great proportion ofHanahan
and Weinberg’s Hallmarks of Cancer.
KEYWORDS
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1 INTRODUCTION
The term cancer covers a spectrum of diseases—cancer
cells can arise from any type of cell in the body and can
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the
original work is properly cited.
© 2021 The Authors. Computational and Systems Oncology published by Wiley Periodicals LLC
grow in or around any tissue or organ making it highly
complex. Tumour cells proliferate, occupying whole areas
of tissue; they interact with surrounding cells, tissue struc-
tures, vasculature and the extracellular matrix (ECM) in a
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F IGURE 1 Schematic diagram showing several key aspects of
the TM: the cancer cells (blue), the ECM fibres (black), the
vasculature (red), vascular-endothelial growth factor (VEGF)
signalling protein (magenta) and immune cells (orange)
variety of ways. In recent years, mathematical and compu-
tational biologists have endeavoured to accurately capture
the growth and development of tumours within their local
environment through in silico models. By simulating vir-
tual tumours, insight is gleaned which complements tra-
ditional biological and experimental approaches to cancer
research at limited financial and ethical cost. This review
paper will focus on highlighting selected lattice-free agent-
based (specifically force-based models) of tumour growth
and development. By way of introduction it will be worth-
while to discuss the importance of approaching the prob-
lem from a mechanical standpoint, as such, in Section 1.1,
the tumour microenvironment (TM) is presented followed
by, in Section 1.2, a discussion of the inherent biomechan-
ics of the TM. In Section 1.3, certain other modelling tech-
niques which have been used to study the dynamics of
tumour growth and development will be highlighted pay-
ing specific attention to where biomechanics have been
successfully implemented.
1.1 The TM
The term tumour microenvironment is given to all aspects
of the local environment of a tumour, consisting of, but
not limited to, the surrounding blood vessels/vasculature,
ECM, tumour-associated immune cells and signalling
molecules/proteins released by the cancer cells (see
schematic in Figure 1). The tumour and the TM are intrin-
sically linked and there is constant interplay and inter-
actions between them, starting from the point of tumour
initiation [1]. Indeed, non-cancerous cells within tissue
respond continuously to the external signals of their envi-
ronment, changing their metabolic state, growth, mito-
sis, gene expression, differentiation, movement or even
undergoing programmed cell death (apoptosis), accord-
ingly. Should the cell fail to correctly transduce or respond
to a specific (external) signal it effectively becomes can-
cerous [2]. A cell with a cancerous phenotype has sev-
eral distinct Hallmarks [2, 3]. For example, cancer cells
resist apoptosis and enable replicative immortality; this
unchecked proliferation creates a tumour (or neoplasm)
within the tissue.
Tumours influence the TM in a variety of different ways.
Hypoxic tumour cells, starved of oxygen, are known to
release vascular-endothelial growth factor (VEGF) which
promotes tumour angiogenesis, supplying the tumour
with constant access to vital nutrient [4, 5]. Equally, as
the growing tumour vies for space within the tissue, cells
release matrix metalloproteinases (MMPs) which degrade
the ECM making room for tumour growth and local inva-
sion [6, 7]. Conversely, the TM affects tumour growth
and development; the shape and size of a tumour; but
also its genetic evolution being determined by proper-
ties of the local environment [8, 9]. For example, cells
migrate preferentially up gradients of ECM stiffness in
a specific type of mechanotaxis called durotaxis [10].
Stiff ECMs can promote tumourigenesis through integrin-
dependent mechanotransduction at focal adhesions [11]
while soft ECMs contribute to phenotypic selection of
tumour-repopulating cells (TRCs) [12]. Indeed, the TMhas
been found to play an active role in the progression of
malignancies [13, 14].
One of the Hallmarks of Cancer is tissue invasion and
metastasis in which tumours spread both locally and non-
locally [2, 3]. Malignant tumours aggressively take over
large areas of tissue, and, of greater concern, are able to
move from primary locations to secondary locations using
the body’s circulatory system. This is a major issue since it
is commonly purported that as many as 90% of all cancer
deaths are due to metastatic spread; note that this figure,
while widely reported and hypothesised [2, 15], is not yet
scientifically proven, although it is true that the majority
of cancer fatalities are due tometastases [16]. Nevertheless,
agent-basedmodels of tumours typically and vitally should
also include aspects of the TM in order to model how can-
cers invade and metastasise.
1.2 Biomechanics in the TM
The focus of this paper is towards force-based models,
and as such it is important to understand why mechanical
interactions are so important. As discussed above there is
constant interplay between a tumour and the TM. Indeed,
the TM governs how a tumour establishes and develops;
the tumour cells respond to mechanical cues actively by
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changing shape, state or migrating. For example, Friedl
and coworkers have shown how the specific nature of
the ECM (it’s density, stiffness and geometry) along with
aspects of the cancer cell (it’s adhesive properties and
polarity) determine how a cell (or a collection of cells)
migrates through tissue [17–21]. Durotaxis was mentioned
above but another type of ‘taxis’ experienced by cells is
haptotaxis [22] which is motility of cells preferentially up
gradients of adhesion within the ECM. More generally,
cells are affected by ‘mechanotransduction’, in which cell-
external mechanical stresses provoke cell-internal chemi-
cal signals leading to some type of adaptive response [23].
For further discussion of mechanotransduction in cancer,
please see the helpful review in [24]. Equally, within the
tumour itself, stresses affect development. Homeostatic
pressure in which a balance of proliferation and apopto-
sis results in zero net growth has been found to limit the
growth of some solid tumours [25, 26]. Conversely, such
mechanical compression (solid stress) may actually drive
cancer cells to invade and metastasise [27–30]. Given the
intrinsic links between cancer cell behaviour and biome-
chanics, in order to fully understand how tumours, initi-
ate, grow, invade and metastasise it is vital to include such
processes in mathematical and computational models.
1.3 Other in silico models
Early mathematical modelling of cancer (avascular solid
tumours) focused on deterministic or continuum models
of solid tumour spheroids developed from the classical
Greenspan model [31]. Such models continue to provide
insight through the ability to efficiently model large-scale
dynamics (typical palpable tumours will contain at least
108 cells [32]) and equally since they lend themselves to
mathematical analysis. For reviews of deterministic and
continuummodels, see, for example, [33, 34]. Selected arti-
cles in which mechanical stress is modelled using a con-
tinuum approach include [1, 35–39] while cell–cell inter-
actions are considered in [40–46], and cell–matrix interac-
tions in [47].
More recently, efforts have been focused on using
individual-based models or agent-based models which
allow a more direct comparison to the biology through
the ability to model at the cell scale and within. In fact,
modelling cell behaviour on the individual level is natu-
rally scale bridging allowing at once intracellular (micro-
scopic) and intercellular (mesoscopic) mechanisms to be
included even when modelling a large number of cells
(macroscopic). Equally, taking an individual approach eas-
ily allows the modelling of heterogenous cell populations
or, at the very least, variability between cells.
1.3.1 On lattice models
The most simplistic agent-based models are cellular
automata models; in general, on-lattice agent based mod-
els have dominated the literature, these can be broadly cat-
egorised into four distinct types (see Table 1). Note, in the
schematics in Table 1 each type is shown on a structured
square lattice, however, on-lattice models often now use
unstructured lattices such as the Voronoi–Delaunay lat-
tice, for example, which typically results in more biolog-
ically realistic shapes, both of cells and cell-masses [49,
76]. On-lattice models may be 3D as in the case of the
classic multicellular tumour spheroid (MCTS) models or
2D as in the case of monolayers. On-lattice models lend
themselves to efficient large-scale simulations of a great
number of cells at little computational cost. Table 1 pro-
vides details of some selected references for state-of-the-
art on-lattice models of tumour growth, specifying the
tumour–TM interactions considered where appropriate.
For further discussion of on-lattice models, see, for exam-
ple, the reviews in [76–82]. On-lattice models typically do
not include mechanics which may be necessary to accu-
rately depict the biology (see discussion above). Types I,
II and IV rely solely on stochastic processes governing
changes of state or position of a cell as well as mitosis.
Cellular-Potts (Type III) is the only type to permit the
modelling of physical mechanisms by solving an effec-
tive energy equation which goes some way to modelling
the forces between cells (see, for example, [83–85]). There
are several open-source on-lattice computational frame-
workswhich include, notably for cancer, theCompuCell3D
Cellular-Potts framework [86] and Chaste (Cancer, Heart
and Soft Tissue Environment) [87, 88].
The remainder of this paper considers lattice-free (or off-
lattice) agent-based, specifically, centre-based, force-based
models of tumour growth and development. It is struc-
tured as follows: in Section 2 the modelling approach is
introduced, in Section 3 the specifics of the forces acting
between cells are outlined and in Section 4 there is a dis-
cussion of selectedmodelling efforts of other aspects of the




Within a lattice-free agent-based model each component
(e.g. cell, tissue fibre or vessel segment) is considered
explicitly. Let us start by considering the most impor-
tant aspect of the TM, the tumour cells themselves.
Each cancer cell, 𝑖, is an individual agent; this paper
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TABLE 1 Summary of on-lattice models with some selected references
Schematic Model description Selected references
Type I - Single cell per lattice site MCTS [48–50]; Allee-effect in
tumour growth [51]; cell–vessel
interactions [52]; cell–cell
interactions [53]; cell adhesion
[54–57]; monolayers [58];
phenotypic heterogeneity [59–62]
Type II - Compartment model.
Multiple cells per lattice site
coarse-grained proliferative rim [63,
64]; exclusion processes [65]
Type III - Single cell covers multiple
lattice sites (Cellular-Potts)
MCTS [66]; cell adhesion [67, 68];
angiogenesis [69]; cell–fibre
interaction [70]; monolayers [71]
Type IV - Multiple (or single) cell(s)
per lattice site, movement though
velocity channels (lattice gas
cellular automata)
MCTS [72]; cell–fibre interaction
[73]; cell–ECM interaction [74];
Allee-effect in tumour growth [75]
F IGURE 2 Schematic diagram indicating the basic physical properties of cells in centre-based models, showing on the left a single cell
in isolation primed for mitosis, in the middle that seed cell having undergone mitosis creating two daughter cells and on the right two mature
cells in contact under a balance of forces
focuses on centre-based models (CBM) in which the
cell geometry is simplified with each cell considered to
be a viscoelastic sphere subject to small deformations,
described by the position of its centre, 𝐱
𝑖
, in the domain
(hence centre-based) and its radius, 𝑅𝑖 , see leftmost image
of Figure 2. When growing tumours of significant size it is
a reasonable assumption/simplification to make that cells
may be represented by spheres. Other tumour models
exist in which cells have non-spherical shape or are fully
deformable, notably the work of Rejniak and coworkers
[89–92]. However, these are not the subject of the review
given here.
The behaviour of tumour cells can be broken down
into three distinct but linked aspects. Firstly, there are
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biological factors such as the cell cycle; each cell has the
ability to grow in size and divide, undergoingmitosis. Once
a cell has reached maturity (proliferative size) it may split
into two daughter cells; mitosis is considered a stochastic
event (taking place randomly, indicated by the DNA
segments on the growth timescale in Figure 2) with prob-
ability inverse to the cell-cycle time. When the mother cell
divides the simplest implementation is to have two smaller
(volume preserving) daughter cells replace the mother cell
(see middle image of Figure 2) [93, 94], more sophisticated
models depict the splitting more accurately by deforming
the spherical mother cell into a dumbbell shape the ends
of which eventually separate into the daughter cells [95,
96]. The daughter cells then grow according to a growth
rate until they too reach proliferative size and experience
forces imposed by each other (see below and Section 3).
Mitosis may be inhibited by external factors such as an
excessive compression force due to a high number of
neighbouring cells, this is commonly referred to as either
contact inhibition [95] or as an exclusion process [97].
Secondly, there are genetic factors; cells may have given
phenotypes or genotypes which prescribe their behaviour
in someway. For example, cell phenotypic evolutionmight
depend on biophysical processes, or biochemical interac-
tions such as the availability of nutrients. This will be dis-
cussed further in Section 4.3.2, in which the traits of cells
with a hypoxic phenotype are compared to the Hallmarks
of Cancer.
Lastly, and particularly key, for force-basedmodels inter-
actions between cells (and indeed other agents in the
model) are described by forces or potentials. Typically,
each cell is governed by an equation of motion, an ordi-













The equation of motion takes into account three main
aspects. Firstly, it accounts for friction experienced by
the cell (first term in Equation 1, in which 𝚪 is a three-
dimensional tensor that models the physical structure of
the environment)—this may be simply background fric-
tion imposed by the tissue but may account for friction
imposed on cells by other structures. Secondly, the cell will
have some pre-described active migration properties (sec-
ond term in Equation 1), these may be as simple as ran-
dom fluctuations/motion as in [93, 94] or may take into
account a cells preferred direction (polarity) as in [98] and
even effects of the external environment (e.g. chemotaxis
where cells are naturally driven up gradients of nutrient,
as in [99]). Thirdly, it incorporatesmechanical interactions
via forces (third term in Equation 1) between a cell and
other agents within the model.
For two cells in contact (determined when the dis-
tance between their centres is less than the sum of their
radii) a force directed along the vector between their cen-
tres, 𝐝
𝑖𝑗
, is calculated taking into account repulsion and
adhesion. Resolving the resulting potential between the
two cells in the absence of any migration terms leads
to two cells which remain stationary under a balance
of forces (see rightmost image of Figure 2). In the fol-
lowing section, we discuss in more detail the repulsion
and adhesion forces between cells. Later we will out-
line interactions of cells with other aspects of the TM
(Section 4).
3 REPULSION AND ADHESION
FORCES
Force-based models are naturally governed by forces,
specifically, repulsion and adhesion forces. In this sec-
tion, the repulsion and adhesion forces acting between
cancer cells are elucidated. The types of model discussed
assume that a cell is spherical in isolation. Thus, any
large contact area between a pair of cells (and indeed
multiple contact areas between a cell and multiple oth-
ers) creates a significant stress on the cytoskeleton of
the cell(s). The limited ability to deform or indeed com-
press (with Poisson numbers found by experiments to be
between approximately 0.4–0.5 [100]) leads to repulsion
between cells. Conversely, cells are naturally adhesive.
For cells in contact, binding due to adhesive molecules
occurs; as the contact area increases so too do the
adhesive bonds. The adhesive molecules at play are
Cadherins (calcium-dependent adhesion) and Catenins,
together these proteins form complexes called adherens
junctionswhich facilitate cell–cell adhesion. Ramis-Conde
and co-authors incorporated the E-Cadherin-𝛽-Catenin
pathway explicitly into their individual -based model
of tumour development in order to discuss the impli-
cations of this pathway on cell migration and cancer
invasion [101–104].
The total cell–cell interaction force between two cells, 𝑖
and 𝑗, directed along the vector, 𝐝𝑖𝑗 , joining their centres








) 𝐝𝑖𝑗‖𝐝𝑖𝑗‖ , (2)
where 𝐅rep
𝑖,𝑗
is the repulsion force discussed in Section 3.1
and 𝐅adh
𝑖,𝑗
is the adhesion force discussed in Section 3.2. In
order to calculate the change in position of cell 𝑖 at each
timestep, the sum of all resulting forces between cell 𝑖 and
any cell 𝑗withwhich it is in contact is included in the equa-
tion of motion (Equation 1).
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TABLE 2 Selected forms of CBM adhesion force with selected references
Adhesive force Description References
|𝐅adh
𝑖,𝑗








Adhesion directly proportional to contact surface area, 𝑆𝑖𝑗 .
The resulting force can be determined explicitly.





𝑎3 − [8𝜋𝛼𝐸∗𝑎3]1∕2 Johnson–Kendal–Roberts (JKR) theory. Contact surface area
(with contact radius parameter 𝑎) is modified by adhesion.
The resulting force must be determined implicitly.
[96, 107, 108]
3.1 Hertzian repulsion
For two spherical cells, 𝑖 and 𝑗, in contact and subject
to small (elastic) deformations, the repulsive force experi-
enced is typically described in the literature by the classi-
cal Hertzian contact mechanics repulsion [105]. The form











where ℎ𝑖𝑗 = 𝑅𝑖 + 𝑅𝑗 − ‖𝐝𝑖𝑗‖ describes the length of ‘over-
lap’ (or contact area) between the two cells. This repul-
sion force term includes both an effective radius, 𝑅∗ =
𝑅𝑖𝑅𝑗∕(𝑅𝑖 + 𝑅𝑗) and an effective Young’s Modulus, 𝐸∗,












where 𝐸𝑖 and 𝐸𝑗 are the cells’ respective Young’s moduli
and 𝜈𝑖 and 𝜈𝑗 their Poisson ratios.
Under Hertzian elastic contact alone, the following
assumptions must be made: (a) strains on the cells are
small and within the elastic limit, (b) the area of con-
tact between the spherical cells is much smaller than
their radii, (c) the cell surfaces are continuous and non-
conforming and (d) there is no friction between the cells.
Moreover, this classical model is strictly non-adhesive.
Cells, however, are naturally adhesive, governed by adhe-
sion molecules that travel to the cellular membrane, stim-
ulated by the proximity of a neighbouring cell, forming
adhesive bonds. Thus, for those modelling mechanical
cell–cell interactions using contact mechanics it is neces-
sary to also include an adhesion force between cells, thus
extending or modifying the classical Hertzian model.
3.2 Adhesion
There are several examples in the literature of cell–cell
interaction forces, with differing expressions for the adhe-
sive force, 𝐅adh
𝑖,𝑗
. Here, we discuss two key variants. These
F IGURE 3 Figure showing how the contact area is estimated
in [93]
are outlined in Table 2 for quick reference and compari-
son. In each case, the force takes into account the strength
of adhesion, 𝛼, which is assumed to be constant among
the cell population and considers the contact surface area
between cells since as contact surface area increases so too
does the number of adhesive bonds.
3.2.1 Explicit adhesion force
In this variant, the adhesion force, 𝐅adh
𝑖,𝑗
, between two over-
lapping cells, is assumed be directly proportional to the
contact surface between them, 𝑆𝑖𝑗 . The contact surface
area is first calculated which then feeds into the adhesion
force. Within the literature, there are different approxima-
tions for the contact surface area. In [106], for example,
they model the contact surface area of cells in contact as
the area of the circle equidistant between the two cells,
underlying the spherical cap of height ℎ𝑖𝑗∕2 (i.e. half the
overlap between cells).While in [93] they calculate the area
to be the average value between the area of the spherical
cap of height the overlap between the cells, ℎ𝑖𝑗 , and area
of the circle underlying the cap (see Figure 3). In this case,
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F IGURE 4 Figures showing the results of a computational
simulation of the growth over time of an MCTS from the CBM of
[94] (unpublished) in which adhesion is incorporated via
Equation (5)
with the resulting adhesion force given by
|𝐅adh
𝑖,𝑗
| = 2𝜋𝛼(𝑅𝑖 − ℎ𝑖𝑗4
)
ℎ𝑖𝑗. (5)
This approach to modelling adhesion considers a ‘suc-
tion’ effect as a consequence of the increasing density of
effective bonds between the cells. In such an approach
certain assumptions have been made [106]. Firstly, it
is assumed that the adhesion molecules (receptors and
ligands) which bind the cells together are distributed
homogeneously over the whole cell surface and thus the
whole contact surface area. Secondly, that binding takes
place instantaneously and furthermore that since adhesion
which causes deformations to the cell naturally change the
cell surface area it is assumed that this process happens
rapidly so that it is not necessary to explicitly consider the
cell surface area.
Figure 4 shows the growth of an MCTS over 3000
time-steps (approximately 2 days) in which adhesion is
modelled by the explicit adhesion force given by Equa-
tion (5). The simulation results shown are derived from
the model (along with parameters) given in [94].
3.2.2 Implicit Johnson–Kendal–Roberts
(JKR) adhesion force
The explicitmodel(s) of adhesion discussed in the previous
section, do not take into account the fact that the adhesion
(derived from the surface contact area) then affects and
modifies the surface contact area. The JKR theory of adhe-
sive contact derives a model for the adhesive force which
includes this hysteresis phenomena [109]. In this case, the
F IGURE 5 Destabilisation of a monolayer using the extended
Hertz interaction (A) and the JKR-interaction energy (B). The
numbers (I), (II), (III) denote the knocked-outcontrol mechanisms
which lead the destabilisation. (I) contact inhibition, (II)
anchorage-dependent proliferation (III) anchorage-dependent
apoptosis (anoikis). Reprinted by permission from Springer Nature
Customer Service Centre GmbH: Springer Nature, Journal of
Statistical Physics, [108], Copyright (2007)










in which 𝐸∗ and 𝑅∗ are, once again, the effective Young’s
modulus and radius, respectively, and 𝑎 is the contact sur-
face radius (see Figure 3). However, in this case 𝑎 is not










Figure 5 is reproduced, with permission, from [108]
(their fig. 5) in which they directly compare the behaviour
of cells governed by (A) an explicit extended Hertzian
model of adhesion (Section 3.2.1) with (B) the JKR theory
model (Section 3.2.2). This study of the destabilisation of a
monolayer shows clearly how the hysteresis effect between
attachment and detachment of cells within the JKRmodel
leads to fewer cells detaching from the substrate over the
same timescale when compared with the extended Hertz
model. For further details of themodel parameters in these
simulations, see [108].
For more details and simulation results of tumour
growth under either the modified Hertzian or JKR adhe-
sion forces see, for example, the references in Table 2.
4 ADDITIONAL ASPECTS OF THE TM
This review will now consider selected modelling efforts
of the mathematical and computational oncology commu-
nity with regards tomodelling tumour–TM interactions. In
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Section 4.1, cell–ECM interactions are discussed while in
Section 4.3 cell–vessel interactions are considered.
4.1 Tumour interactions with the ECM
The ECM, on a basic level, is composed of a structured
mesh (matrix) of fibres (e.g. collagen and fibronectin)
within a gel of glycoproteins.We have previously discussed
cell–cell adhesion but another important adhesive process
in cell biology is cell–matrix adhesion. Focal adhesions
are protein complexes which connect the cell’s cytoskele-
ton to the ECM [11, 110]. Focal adhesions not only directly
and mechanically link the cell to the ECM but they also
act as points of signalling (mechanotransduction); trans-
mitting information about the mechanics of the extracel-
lular environment to cells through biochemical signalling
molecules. Focal adhesion mechanotransduction plays an
important role in regulating both the shape and migration
of cells [11]. Specific focal adhesion proteins which act as
mechanotransducers are the ECMprotein, fibronectin and
cell-membrane receptor integrins. Fibronectin also binds
to collagen fibres in the ECM. Collagen fibres give struc-
ture to tissue but also, naturally, by extension, to the TM.
Furthermore, cell–ECM interactions may have a lasting
impact on the structure of the ECM.Modelling of the ECM
(and cells) typically considers it (them) to be primarily vis-
coelastic, however, upon interaction they may exhibit a
degree of plasticity—changing shape and structure perma-
nently (or at least until the next interaction). Such plastic
deformation of the fibrous ECM structure is often charac-
teristic of the TM; fibres, for example, align around solid
tumours [111–113].
The fibrous connective tissue of the ECM performs a
wide variety of functions within the healthy body. In terms
of cancer, and within the TM, the structure of the ECM
and the interaction of cancer cells with individual fibres of
the matrix drive almost all aspects of cell behaviour from
its proliferation to migration. ECM binding is implicated,
for example, in proliferative signalling; experimental data,
backed up by in silicomodels, have shown that border cells
(those connected to the ECM) of an MCTS are less prolif-
erative than cells in the interior [49]. Moreover, malignant
cells activate the ‘integrin migration pathway’ and crawl
towards and along the protein network of the ECM;migra-
tion through the protein network results in the rearrange-
ment of the ECM structure as cancer cells use the integrin
pathway to cut-off the fibres and re-orient the ECM [114,
115]. Cell migration can happen as a collective process that
presents in different ways depending on the tumour type
and the nearby environment leading to different migration
structures [18, 20].
The physical properties of the environment itself affect
tumour development and progression. It is widely known
that cells prefer stiff matrices to softer ones (durotaxis,
[10]). Tumours themselves are known to be stiffer than
normal tissue [116, 117]. The stiffness of the ECM not
only affects cell–ECM adhesion (and as such modulates
cell-spreading and migration, [118]) but it also affects the
epigenome altering the cancer cell pheno- and genotypic
behaviour [8, 9, 119]. It has been shown that stiff ECM pro-
motes tumour progression [120, 121]. On the other hand, it
has been shown that TRCs are more proliferative in soft
rather than stiff environments [12]. To fully understand
cancer development and local tissue invasion, it is impor-
tant tomodel the ECMalongside the cancer cells. Tomodel
the ECM, it is natural to incorporate fibres as additional
agents within an agent-based model.
4.2 Cell–fibre interactions
It is worthwhile to begin this section by referring to the
movement mechanisms of cells. The spatial behaviour
of cells (including their movement) is governed by their
polarity. Epithelial cells, for example, have apical-basal
polarity, while migratory cells are polarised with front-rear
polarity [122]. Changes in a cell’s polarity phenotype is
characteristic of both tumourigenesis [123] andmetastases
[124]. Within the TM when cells encounter ECM fibres
they adhere to them and ‘crawl’ along them [125] poten-
tially re-modelling the ECM in their wake [126].
In [98], the ECM fibres are modelled using a force-
based, individual-based model in which cells adhere to
fibres causing changes to the directionalmovement of cells
but also accounts for restructuring of the fibres. Single-
cell experiments are carried out to determine the effect
that the cell’s environment (in this case a 2D substrate)
has on its migration. By placing a single cell in a domain
segregated by substrates with different matrix stiffnesses
[98] were able to reproduce the experimental results of
[10] showing that cells are drawn preferentially to stiffer
matrices, hypothesising that it was the lack of matrix
reorientation by the cell that drives durotaxis. In a sec-
ond experiment, they showed the observable ‘follow-the-
leader’ behaviour of collective cellmigration [127]. Figure 6
reproduces, with permission, their fig. 10, in which a sin-
gle non-polarised cell becomes polarised and ‘follows’ the
path of polarised ‘leader’ cell. It can also be seen from these
experiments how the ECM is re-modelled in the wake of
the cell’s path, fibres having been realigned as the cells
have passed through.
In [94], the 2D model of [98] is extended to 3D and
matrix fibres are incorporated into a CBM for tumour
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F IGURE 6 Snapshots in time indicating how two cells collectively migrate through the matrix. A non-polarised cell (red in plot A)
becomes polarised (turning green) and then follows the path of the existing polarised cell (green in plot A). Reprinted from [98], Copyright
(2012), with permission from Elsevier
growth. Each individual fibre is modelled explicitly by
a thin cylinder (described by its extrema and radius),
and the three-dimensional computational domain is
filled with fibres of a given distribution of positions and
orientations. In this work, the movement of cells along
fibres is modelled by extending the force-based approach
to cell–fibre interactions by incorporating attractive and
repulsive forces between cells and fibres which cause
cells to move along fibres; a cell in contact with a fibre
will feel an adhesive force, parallel to fibre orientation
and a repulsive force orthogonal to the fibre [128]. A
cell–fibre interaction force is computed as the sum of
these orthogonal/repulsive and parallel/adhesive terms,
and added to the right-hand side of the equation of motion
of each cell (Equation 1); the form of these forces can be
found in [94].
Figure 7, reproduced, with permission, from [94] (their
fig. 4) shows how a tumour develops oriented along fibres
which are uniformly distributed aligned with the 𝑦-axis.
Initially a single cancer cell is placed within a fibrous
domain, the resulting tumour which has developed (after
9000 timesteps, approximately 6 days) is shown inFigure 7.
Whereas, in the absence of fibres, one would typically see
a spherical tumour mass form (as in Figure 4), here the
growth has been stretched out along the fibrous tissue.
Themodel in [94], however, overly simplifies the biology
underpinning cell–fibre interactions. It does not account
for the reverse mechanical processes in which cells affect
the fibres; in order to gain tractability as a 3D model the
simplification of fixed fibreswasmadeunlike the 2Dmodel
in [98]. In reality, individual fibres and the matrix as a
whole are plastic as described above and so also move and
re-model around an invading tumour or single invading
cell. Furthermore, it may well be the case that rather than
preserving polarity and moving along fibres unidirection-
ally migrating cancer cells may repeatedly reverse their
polarity and move periodically up and down matrix tracks
as in the single-cell experiments of [129].
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F IGURE 7 Figures showing the results of a simulation of tumour growth within a domain of uniformly distributed fibres (aligned with
the 𝑦-axis) after 9000 timesteps. Cells are represented by red spheres, fibres in grey. Left: View orthogonal to the fibre orientation (𝑥𝑧-plane).
Right: View in the 𝑦𝑧-plane, cropped on the left side. Reprinted from [94], Copyright (2020), with permission from Elsevier
A further biologically relevant aspect that links cancer
cells to the ECM is matrix re-modelling by degradation.
MMPs are enzymes which degrade ECM proteins (e.g. col-
lagen fibres) through proteolysis. Proteolytic re-modelling
of the ECM by MMPs is a key step towards cancer inva-
sion [6]. Fibre degradation is taken into account in current
state-of-the-art continuummodels, see, for example, [130].
The use of forces to model tumour–TM interactions
is only one way to account for the inherent biomechan-
ics, alternative models of cell–ECM interactions include
[131], for example, who use Hookean springs which act
via the basement membrane which links cells to the con-
nective tissue. Biomechanics though are vitally important
to the functioning of the ECM; a comprehensive review
of ECM mechanics and how this interplays with cellular
behaviour can be found in [132] while discussion of ECM
re-modelling and its role in tumour progression andmetas-
tasis can be found in [126].
4.3 Tumour interactions with the
Vasculature
Another important aspect of the TM is the vasculature.
Blood vessels weave through the tissue supplying it with
oxygen and other vital nutrients. Cell–vessel interactions
are both mechanical and biochemical.
4.3.1 Mechanical cell–vessel interactions
Cells interact mechanically with segments of the vessel
network. In [94], they assume that repulsive and adhe-
sive forces act between a cell and a vessel segment and
that these forces are analogous to those between cells (Sec-
tion 3), for further details, see [94]. Their simulations show
tumours developing and embedding within pre-existing
vasculature. The proliferation of cancer cells around blood
vessels—modelling so-called ‘tumour cords’ is simulated
F IGURE 8 Simulation results of a tumour cord interacting
with two blood vessels (black cells are necrotic). (A-B) Tumour cord
growing around two vessels, (C) oxygen profile levels in the tumour
cord, (D) cross-section showing corresponding development of
tumour cells. Reprinted by permission from Springer Nature
Customer Service Centre GmbH: Springer Nature, Bulletin of
Mathematical Biology, [99], Copyright (2018)
in [99]. In the case of a tumour chord rather than a
spherical tumour growing with the classical radial profile
(necrotic core, quiescent and proliferative outer ring), the
opposite profile is derivedwith necrotic regions on the out-
side furthest away from the central blood vessel(s). Figure 8
is reproduced, with permission, from [99] (their fig. 15).
In order for cancer to metastasise and spread to sec-
ondary sites around the body, cancer cells must be able to
access the vessel network. Intravasation (and its analogous
reverse, extravasation) is the process by which a cell enters
(or leaves) the vascular network. In [102], they model
the key metastatic process of intravasation using a CBM
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F IGURE 9 Spatiotemporal evolution dynamics of a malignant cell (red nucleus coloured cell, marked with a full arrow) approaching a
blood vessel to undergo TEM. When the malignant cell attaches to the vessel, the VE-cadherin bonds are disrupted and new N-cadherin
bonds are formed (shown in yellow). After some time, the malignant cell manages to disrupt the endothelial bonds enough to open a gap in
the vessel and undergo TEM. Copyright IOP Publishing. Reproduced with permission from [102]. All rights reserved
coupled to a deterministic model of the intracellular pro-
tein pathways which allow cells to migrate through the
vessel endothelial wall (transendothelial migration, TEM)
[133, 134]. In this case, adhesion of the cancer cell with the
vessel endothelia is key, and as before adhesion is driven by
cadherins. Vascular endothelial cadherins (VE-cadherin)
bind the cells of the vessel wall together. A cancer cell dis-
rupts endothelial bonds binding itself to the wall using N-
cadherin. Figure 9 is reproduced, with permission, from
[102] and shows a single cell approach and then intravasate
a vessel wall.
4.3.2 Biochemical interactions: The hypoxic
phenotype
Cancer cells, like normal cells, respond to the availability
of oxygen, although the malignant response is anything
but normal. We can characterise cancer cells into phe-
notypes based on their access to oxygen (e.g. normoxic,
hypoxic and necrotic). Hypoxic cells are chronically lack-
ing in sufficient oxygen, this deficiency of the main cell
nutrient rather than being tumour suppressing actually
drives tumour progression in numerous ways [5]. Jain lists
the following responses of tumour cells to hypoxia: switch
to anaerobic metabolism; resist apoptosis; undergo the
epithelial–mesenchymal transition (EMT); induce a can-
cer stem-cell ‘repopulating’ phenotype, resist anti-cancer
therapies; cause inflammation and immunosuppression;
genomic instability and angiogenic. Notice that these clas-
sical behaviours are closely aligned with the Hallmarks of
Cancer [2, 3]; the hypoxic phenotype is what drives cancer
progression and makes it so deadly.
Hypoxia is a main driver of the EMT) [135]. The EMT
occurs when epithelial cells detach (losing their cell–
cell adhesion and polarity) and gain mesenchymal cell
attributes (migration, invasion and differentiation). The
EMT is the first step towards cancer metastasis. In [136],
they model the EMT and metastasis using a hybrid on-
lattice individual-based approach. Hypoxia also drives
angiogenesis, with hypoxic tumour cells releasing VEGF
which signals for tumour angiogenesis. McDougall and
co-workers are leading experts in modelling angiogenesis
[137–141]. In [93], they incorporate normoxic, hypoxic and
necrotic phenotypes into a CBM to show how the hypoxia
phenotype is implicated in the formation of pseudopal-
isades (hypercellular ‘walls’ surrounding necrotic zones)
in glioblastoma.
5 CONCLUSIONS
This paper provides a selected review of in silico models
for tumour growth and development, with specific empha-
sis on centre-based force-based agent-based models. For a
critical evaluation of the available agent-based modelling
techniques, their advantages and disadvantages including
discussion of computational costs, see, for example, [76].
A great many authors are contributing to this vibrant area
of research as shown throughout the paper and the refer-
ences herein. Specifically, key authors in the field include
Drasdo and coworkers [95, 107, 108, 142–146]. However, no
review of such models would be complete without men-
tioning the work of Macklin and co-authors [147–149] who
have recently launched PhysiCell a comprehensive open
source C++ code designed to simulate the growth 3D cell
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colonies with natural applications to growing tumours.
Cell mechanics are modelled in much the same way as
described here with adhesion and repulsion forces acting
both between cells and their environment. The environ-
ment itself is modelled though reaction-diffusion partial
differential equation (PDEs) making it what is commonly
described of as a hybrid model. For details of this power-
ful tool, we direct the reader to the code guide [150]. In
particular, one aspect of the TM which has not been dis-
cussed here, although which is a vital part, are tumour-
associated immune cells; PhysiCell has been used to model
how immune cells attack an MCTS [150], other agent-
based models of tumour immune interactions—include
[151–154]. Szymańska and co-workers are also develop-
ing hybrid models in which individual cells are treated as
agents while the environment is described as a continuum
[155–157], in such a case while computational efficiency is
enhanced the nuances of specific environmental biome-
chanics, such as movement along fibres, are lost.
Beyond highlighting state-of-the-art research in the
field, the main take home message is that biomechan-
ics need to be taken into account. One might contrast
individual-based models with reaction-diffusion models
of cancer. While reaction-diffusion models (for example,
[158–160]) do offer insight they do not include biome-
chanics nor can they account for phenotypic variations
that are well captured through an agent-based force-
based approach. Even for the subset of reaction-diffusion-
taxis models (161], for example) where biomechanics may
be implied they are not taken into account explicitly.
Individual-based modelling, then, has significant advan-
tages over reaction-diffusion models in determining the
key mechanisms which drive metastatic spread. Perhaps
in the future greater effort should be put into integrating
reaction-diffusion models with biomechanics in order to
gain the advantages of both approaches.
Agent-based modelling of tumour growth, however, is
just a single strategy in the global effort of the scientific
community in the fight against cancer. Indeed, mathe-
matical (and computational) oncology is a growing field
in which research is being done on a broad range of topics
spanning from modelling intracellular genetic pathways
(see, for example, [162–164]) to modelling cancer therapies
(see, for example, [165–167]). Looking to the future, a
multi-scale model of a growing tumour within the TM
should seek to bring together not only the biomechanical
aspects laid out above but equally other aspects from the
diverse field of study. By incorporating intracellular path-
ways (such as in [101, 103]) which results in phenotypic
differences between cells it is possible to derive a realistic
heterogeneous cancer cell population. By using imaging
combined with the modelling techniques above to render
in vivo tumours in silico it is possible to simulate in real
time and space the development of tumours predicting
how they will invade and metastasise. By trialing cancer
therapies on in silico tumours (as in [50, 141, 168]) clini-
cians can devise optimal therapy protocols that can at once
become both the standard of care and patient-specific. In
combination, these techniques will truly push the frontier
of our understanding of cancer and lead towards person-
alised medicine where each patient can be treated truly
individually.
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